C6orf15 and central nervous system cancer: Our studies have already identified key rate-limiting genes, such as dCyclinE, Stg, and dMyc, and genes only required for abnormal neoplastic glial proliferation, such as dSin1, dRictor, and dCdk4, which may represent important therapeutic targets in human gliomas.